Simultaneous versus Sequential Transcatheter Arterial Chemoembolization Combined with Microwave Ablation for Unresectable Hepatocellular Carcinoma: A Retrospective Propensity Score–Matched Analysis

After propensity scoring, we screened 76 liver cancer patients who received transcatheter arterial chemoembolization (TACE) combined with microwave ablation treatment, including a simultaneous treatment group of 36 cases and a sequential treatment group of 40 cases. Simultaneous TACE and MWA combination therapy is usually completed in the first hospital cycle with treatment intervals of 1–3 days. Patients in the sequential treatment group usually undergo 1–3 palliative TACE treatments before microwave ablation. These raw data include patient age, gender, tumor characteristics, liver function before and after treatment, short-term tumor response, as well as time to progression and overall survival time.

经倾向性评分分析后，我们筛选纳入76例接受经导管动脉化疗栓塞（transcatheter arterial chemoembolization, TACE）联合微波消融（microwave ablation, MWA）治疗的肝癌患者，其中同步治疗组36例，序贯治疗组40例。同步TACE联合MWA治疗方案通常于首次住院周期内完成，两次治疗间隔为1~3天。序贯治疗组患者则通常先接受1~3次姑息性TACE治疗，再行微波消融治疗。本数据集的原始数据涵盖患者年龄、性别、肿瘤特征、治疗前后肝功能指标、短期肿瘤应答情况，以及疾病进展时间与总生存时间。